Briacell Therapeutics Corp. Common Shares BCTX
$3.44
+0.00%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $40.00
- Implied Upside
- +1062.8%
- Price Target Range
- $40.00 – $40.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-08-27 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $32 → $40 |
| 2025-04-22 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $32 |
| 2025-02-03 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $15 → $32 |
| 2024-12-12 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $225 |
| 2024-12-03 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $225 |
| 2024-10-03 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $225 |
| 2024-09-19 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $270 → $225 |
| 2024-09-11 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $270 |
| 2024-06-04 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $270 |
| 2024-05-24 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $270 |
| 2023-12-28 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $270 |
| 2023-10-03 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $375 → $300 |
| 2023-06-28 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $375 |
| 2023-02-24 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $375 |
| 2022-02-14 | HC Wainwright & Co.Emily Bodnar |
Initiates coverage on | Buy | $375 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.44
- Market Cap
- $29.93 million
- 52-Week Range
- $2.60 – $20.80
- Average Volume
- 136K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.